The United States is lifting the moratorium on Johnson & Johnson’s ticker. The Center for Disease Control and Prevention (CDC) has approved the resumption of Johnson & Johnson’s vaccination program. However, warnings have been issued about the risk of blood clots.
According to the BBC, local time on Friday afternoon, the CDC and the Food and Drug Administration lifted the suspension of Johnson’s vaccine following a recommendation from the CDC’s advisory panel.
Vaccination may begin in several US states shortly after the directive is revoked. This week, Europe’s drug regulator Johnson & Johnson lifted restrictions on vaccines.
About 9.5 million Johnson & Johnson vaccines are unused in the United States.
The U.S. government’s advisory board considers the use of the vaccine to be more important to protect public health than the slight risk of side effects. However, there will be cautious when taking the vaccine. Women under the age of 50 are at risk for side effects such as blood clots.
About 7 million people in the United States have been vaccinated against Johnson. Of these, 15 cases of side effects have been detected. All of them are women and most of them are below 50 years of age.
An adequate supply of Pfizer-BioEnTech and Modern vaccine has been ensured, the Biden administration said.
